Evidence map›Paper›PMID 40375771›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial.

Valeria Paradies, Nicolas M Van Mieghem, Rohit M Oemrawsingh, Gert Richardt, Giovanni Esposito, Gianluca Campo, Francesco Burzotta, Paolo Canova, Axel Linke, Italo Porto and 9 more

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Valeria ParadiesDepartment of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.
Nicolas M Van MieghemDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rohit M OemrawsinghDepartment of Cardiology, Amphia Hospital, Breda, the Netherlands.
Gert RichardtDepartment of Cardiology, Asklepios Klinik Bad Oldesloe, Bad Oldesloe, Germany.
Giovanni EspositoDepartment of Advanced Biomedical Sciences, University of Naples "Federico II, Naples, Italy.
Gianluca CampoCardiology Unit, Azienda Ospedaliero Univesitaria di Ferrara, Cona (FE), Italy.
Francesco BurzottaFondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Paolo CanovaOspedale Papa Giovanni XXIII, Bergamo, Italy.
Axel LinkeCardiology Department, Heart Center Dresden University, Dresden, Germany.
Italo PortoCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Daniela TrabattoniDepartment of Interventional Cardiology, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Koen TeeuwenCardiology Department, Catharina Hospital, Eindhoven, the Netherlands.
Tom AdriaenssensDepartment of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium and Department of Cardiovascular Sciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Petr KalaThe University Hospital Brno, Medical Faculty of Masaryk University, Brno, Czech Republic.
Goran StankovicDepartment of Cardiology, University Clinical Center of Serbia, Belgrade, Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Ria van VlietDepartment of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.
Daniele GiacoppoDepartment of General Surgery and Surgical-Medical Specialties, University of Catania, Catania, Italy.
Joost DaemenDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pieter C SmitsDepartment of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monotherapy with a potent P2Y

Indexed as

Percutaneous Coronary InterventionPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsST Elevation Myocardial InfarctionTomography, Optical CoherenceCoronary AngiographyEquivalence Trials as TopicHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicTreatment OutcomePlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor Antagonists

Identifiers

PMID40375771
PMCPMC12063550

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.